These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16378590)

  • 1. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
    Wang Q; Mosser DD; Bag J
    Hum Mol Genet; 2005 Dec; 14(23):3673-84. PubMed ID: 16239242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
    Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.
    Fan X; Messaed C; Dion P; Laganiere J; Brais B; Karpati G; Rouleau GA
    Can J Neurol Sci; 2003 Aug; 30(3):244-51. PubMed ID: 12945950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamism of PABPN1 nuclear inclusions during the cell cycle.
    Marie-Josée Sasseville A; Caron AW; Bourget L; Klein AF; Dicaire MJ; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2006 Sep; 23(3):621-9. PubMed ID: 16860991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.
    Klein AF; Ebihara M; Alexander C; Dicaire MJ; Sasseville AM; Langelier Y; Rouleau GA; Brais B
    Exp Cell Res; 2008 May; 314(8):1652-66. PubMed ID: 18367172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.
    Banerjee A; Phillips BL; Deng Q; Seyfried NT; Pavlath GK; Vest KE; Corbett AH
    J Biol Chem; 2019 May; 294(18):7360-7376. PubMed ID: 30837270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
    Roth F; Dhiab J; Boulinguiez A; Mouigni HR; Lassche S; Negroni E; Muraine L; Marhic A; Oliver A; Lainé J; Rouche A; O'Ferrall EK; van Engelen B; Ottenheijm C; Greif H; Blumen S; Lacau St Guily J; Perie S; Butler-Browne G; Mouly V; Trollet C
    Acta Neuropathol; 2022 Dec; 144(6):1157-1170. PubMed ID: 36197469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
    Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
    Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation.
    Davies JE; Sarkar S; Rubinsztein DC
    Hum Mol Genet; 2008 Apr; 17(8):1097-108. PubMed ID: 18178579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.
    Bhattacharjee RB; Zannat T; Bag J
    Cell Biol Int; 2012 Aug; 36(8):697-704. PubMed ID: 22519734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.
    Raz V; Sterrenburg E; Routledge S; Venema A; van der Sluijs BM; Trollet C; Dickson G; van Engelen BG; van der Maarel SM; Antoniou MN
    BMC Neurol; 2013 Jul; 13():70. PubMed ID: 23815790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.
    Corbeil-Girard LP; Klein AF; Sasseville AM; Lavoie H; Dicaire MJ; Saint-Denis A; Pagé M; Duranceau A; Codère F; Bouchard JP; Karpati G; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2005 Apr; 18(3):551-67. PubMed ID: 15755682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
    García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
    J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death.
    Fan X; Dion P; Laganiere J; Brais B; Rouleau GA
    Hum Mol Genet; 2001 Oct; 10(21):2341-51. PubMed ID: 11689481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies.
    Abu-Baker A; Rouleau GA
    Biochim Biophys Acta; 2007 Feb; 1772(2):173-85. PubMed ID: 17110089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression.
    Kim YJ; Noguchi S; Hayashi YK; Tsukahara T; Shimizu T; Arahata K
    Hum Mol Genet; 2001 May; 10(11):1129-39. PubMed ID: 11371506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy.
    Hino H; Araki K; Uyama E; Takeya M; Araki M; Yoshinobu K; Miike K; Kawazoe Y; Maeda Y; Uchino M; Yamamura K
    Hum Mol Genet; 2004 Jan; 13(2):181-90. PubMed ID: 14645203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1.
    Catoire H; Pasco MY; Abu-Baker A; Holbert S; Tourette C; Brais B; Rouleau GA; Parker JA; Néri C
    Hum Mol Genet; 2008 Jul; 17(14):2108-17. PubMed ID: 18397876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.